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ABSTRACT
Lytic replication of the human gamma herpes virus
Epstein-Barr virus (EBV) is an essential prerequisite
for the spread of the virus. Differential regulation of
a limited number of cellular genes has been reported
in B-cells during the viral lytic replication cycle. We
asked whether a viral bZIP transcription factor, Zta
(BZLF1, ZEBRA, EB1), drives some of these changes.
Using genome-wide chromatin immunoprecipitation
coupled to next-generation DNA sequencing (ChIP-
seq) we established a map of Zta interactions across
the human genome. Using sensitive transcriptome
analyses we identified 2263 cellular genes whose
expression is significantly changed during the EBV
lytic replication cycle. Zta binds 278 of the regulated
genes and the distribution of binding sites shows
that Zta binds mostly to sites that are distal to tran-
scription start sites. This differs from the prevailing
view that Zta activates viral genes by binding exclu-
sively at promoter elements. We show that a syn-
thetic Zta binding element confers Zta regulation at
a distance and that distal Zta binding sites from cel-
lular genes can confer Zta-mediated regulation on
a heterologous promoter. This leads us to propose
that Zta directly reprograms the expression of cellu-
lar genes through distal elements.
INTRODUCTION
Epstein–Barr virus represents a serious health threat both in
the developing world and in western economies and is a sig-
nificant risk factor forHodgkin’s lymphoma (HL), Burkitt’s
lymphoma (BL) and nasopharyngeal carcinoma (NPC) (1–
4). Primary infection with EBV is also responsible for the
development of infectious mononucleosis (5). Infection of
resting primary B-lymphocytes by EBV generates a popu-
lation of cells that are effectively immortal. This represents
the first step in the establishment of life-long viral latency
in vivo and generates precursors that can develop into lym-
phoid malignancies (6,7).
EBV genes fall primarily into two groups, depending on
their patterns of expression, and are classified as either la-
tent or lytic (6,7). During latency, the majority of the vi-
ral genome is silenced and only a restricted set of genes
is expressed (6,7). Once EBV lytic cycle replication is ini-
tiated, the lytic cycle genes are transcriptionally activated
(8,9). Some lytic cycle genes are also expressed following in-
fection of B-lymphocytes by EBV, but this does not result
in a full lytic replication cycle (10–13) and has been termed
a pre-latency phase (14).
The switch from viral latency to the lytic replication cycle
is critical for virus spread. A key executioner of this pro-
cess is the transcription and replication factor Zta (BZLF1,
ZEBRA, EB1, Z) (9,15). This AP-1-like viral protein is
a member of the bZIP family and interacts with a seven
base-pair DNA sequence element termed Zta-response el-
ement (ZRE), for which at least 32 sequence variants are
known (16,17). A sub-set of ZREs contain a CpGmotif and
are only recognized as ZREs when the DNA is methylated
(11,18,19). DNA binding analyses across the EBV genome
by ourselves and others revealed that Zta interacts exten-
sively with viral promoters and with the viral origins of lytic
replication (16,20). The current model of Zta function is
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that it acts at promoter-proximal regions to recruit RNA
polymerase II and associated factors (15).
As well as regulating viral genes, Zta has the potential
to alter the patterns of gene expression in the host cell. Zta
is known to regulate the expression of a few cellular genes
such as FOS (21), E2F1 [23], EGR1 (22,23), IL8 (24), IL10
(25) and IL13 (26). Furthermore, attempts have been made
to obtain a global map of cellular genes regulated during
EBV replication using an EBV-positive BL cell line induced
to initiate viral replication (27,28). However, as only a mi-
nority of the cells in a given population responds to the acti-
vating stimulus, this approach detected only themost highly
activated genes.
Here, we undertook an unbiased genome-wide survey to
map cellular genes that are bound by Zta. We then gener-
ated a cell system that allows enrichment of cells undergo-
ing lytic cycle to perform sensitive transcriptome analyses of
changes in expression of cellular genes during the lytic cycle.
Integrating these data-sets led us to propose that Zta is able
to regulate the expression of cellular genes through interac-
tions with distal elements as well as through promoters, and
we present further evidence to support this hypothesis.
MATERIALS AND METHODS
Cell lines
The Akata group I EBV-positive BL cell line (29), an EBV-
immortalized lymphoblastoid cell line, LCL#3 (30) and an
EBV-negative BL cell line, DG75 (31), were maintained in
RPMI medium supplemented with 10% (v/v) fetal bovine
serum, 100 units/ml penicillin, 100g/ml streptomycin and
2 mM L-glutamine (Life Technologies) at 37◦C with 5%
CO2. For EBV lytic induction, Akata cells were seeded in
log phase growth at 5×105cells/ml. After 24 h, the cells were
concentrated to 2 × 106 cells/ml and treated with 0.125%
rabbit anti-human IgG (DAKO) or Dulbecco’s phosphate
buffered saline (DPBS) for the indicated times, in the pres-
ence or absence of acyclovir (Sigma) to capture both early
and late lytic stages of viral replication (20). HONE1-EBV
cells were maintained in the same medium and the pres-
ence of EBV within the cells was maintained by selection
with 600 g/ml G418. For EBV lytic replication cycle in-
duction, HONE1-EBV cells were grown to 70% confluence
and induced with 10 M suberoylanilide hydroxamic acid
(SAHA) for 48 h.
The expression vector pRTS-CD2-BZLF1, which drives
expression of Zta, non-functional NGFR and GFP from
a bi-directional doxycycline-regulated promoter and CD2
from a constitutive promoter or a control vector in which
the BZLF1 sequences are cloned in the reverse orientation
(32), were introduced into the Akata cell line by electro-
poration. Cells harboring the plasmids were physically en-
riched on the basis of CD2 expression, generating Akata-
Zta and Akata control cells as described (32). Expression
of the doxycycline-regulated promoter was induced by ad-
dition of 500 ng/ml doxycycline for 4–24 h and NGFR-
expressing cells were isolated with anti-NGFR antibodies
coupled to paramagnetic beads as described (32). Viable cell
counts were assessed by trypan blue (Sigma) exclusion.
FACS and protein analyses
GFP-positive cells were detected using multi-parameter
fluorescent activated cell analysis (FACs) (Facs Canto-
Beckton Dickinson). Intracellular staining of Zta was un-
dertaken with the mouse monoclonal antibody BZ1 (33),
with anti-mouse IgG coupled to Donkey F(ab’)2 as a sec-
ondary reagent (anti-mouse IgG -Alexa Fluor R© 647) and
the FIX & PERMR© Cell Permeabilization Kit (LifeTe-
chologies). Intracellular staining of VCA was undertaken
with themousemonoclonal antibodyVCA-gp125 (clone L2
MAB8184, Millipore) and the same secondary reagent and
conditions. Dual parameters of GFP and Alexa-fluor 647-
coupled staining were collected and the double positive cells
identified using BDFACSDivaTM Software (BecktonDick-
inson).
Cells were harvested in sample buffer (4% SDS, 20% glyc-
erol, 10% 2-mercaptoethanol, 0.004% bromophenol blue
and 0.125 M Tris–HCl, pH 6.8.) and total proteins were
fractionated by SDS-PAGE in a 12% gel (Novex). After
transfer to nitrocellulose membrane, Zta and actin were de-
tected by immunoblotting with the BZ1 mouse monoclonal
antibody against Zta (33) and a rabbit antibody against -
actin (Sigma). Species-specific IR-labeled anti-mouse and
anti-rabbit antibodies (Licor) were used in the second layer
and the resulting signal was detected on an Odyssey Fc Im-
ager and quantified using Odyssey Image Studio (Licor).
Luciferase reporter assays
A 239 bpDNA element comprising 20 non-CpGZREs (17)
with a spacing element of 4–6 nucleotides between each
was synthesized as complimentary oligonucleotides (Gene
Strings––Life Technologies) and inserted between the SalI
and BamH1 sites at the enhancer cloning site of the pGL3-
enhancer reporter vector (Promega). Two minimal promot-
ers, one from the cell CIITA gene (−214/+54) and the mini-
mal promoter from the pGL4.23 reporter vector (Promega)
(Supplementary Figure S4) were cloned upstream of the
firefly luciferase sequences between the HindIII and Kpn1
restriction enzyme sites. The sequences of the cloned ele-
ments were verified (Eurofins). The viral BHLF1 promoter
with the ZREs mutated was cloned upstream from the lu-
ciferase reporter gene in pCpGL luciferase reporter vector
(34) and the Zta binding sites from the cellular FOSB gene
and another region of cellular DNA were cloned upstream
from it (Supplementary Figure S4). Zta binding sites≥40kb
downstream from the TSS of RASA3 were cloned into
pGL3-enhancer reporter vector (Promega) and the mini-
mal promoter from the pGL4.23 reporter vector was added
(Promega) (Supplementary Figure S4).
Different DNA combinations comprising 5 g of the rel-
evant reporter construct and 5 g of an expression vec-
tor for His-tagged Zta, or the corresponding empty vector
control (35), were introduced into 1.2 × 107 DG75 cells,
an EBV-negative BL line (31), by electroporation with the
Gene pulser II (Biorad). After 24 h, half of the cells were
harvested into 250 l of 1× passive lysis buffer (Promega),
and luciferase activity was determined using the luciferase
assay system (Promega). Light emission was measured in
relative light units (RLU) using theGloMaxmulti detection
system (Promega). The remaining cells were harvested into
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Table 1. Primers used for Q-PCR assays
5′ flank Zta peak 3′ flank
SCIMP Forward primer
CCCTCGTGCAATACTGTGAGA
Forward primer
TTGCACAGCAAGTTCAAGCC
Reverse primer
ACAACTCATTCGCTCTGGGC
Reverse primer CTTTCTTGAAGG
CAGATGGCAA
BCL2A1 Forward primer
AGGAATTTGGCCTCCCAATCA
Forward primer
TCTTGAGCTGGCTCACCTTG
Forward primer ACAGTGGTTACC
TCTTGGGAGA
Reverse primer
TTTCTCCAGCGACCATGAGTT
Reverse primer
AAACACAGCCTACGCACGAA
Reverse primer CCTGTGTTGAAA
CTCATGTTGGTA
A 
7.5E-094    
Non CpG ZRE 
9.5E-035 
CpG ZRE 
≤2 kb 2-4 kb ≥4 kb 
B 
Figure 1. Zta binding across the human genome. ChIP-Seq was undertaken with an antibody against Zta protein using chromatin from Akata BL cells
induced to enter EBV lytic replication cycle by cross-linking the B-cell receptor with anti-IgG. The DNA bound by Zta was aligned to the human genome
and peaks of Zta binding were identified using model-based analysis of ChIP-seq (MACS). (A) The proportions of genes associated with proximal (<2
kb from TSS), intermediate (2–4 kb) and distal (>4 kb) Zta binding sites is shown. (B) The presence of common DNA sequence motifs within the Zta
binding sites was determined usingMEME-ChIP. The enriched motifs are colored together with the significance of the enrichment. The related ZREmotif
is shown below each in black (17).
protein sample buffer and the levels of Zta were determined
by immunoblotting (as described above). For each sample,
relative promoter activity was determined from the ratio of
luciferase activity to protein level and the assays were per-
formed in triplicate.
ChIP
Surface IgG on Akata cells was cross-linked by application
of anti-IgG and 48 h later chromatin was prepared from 1×
108 cells. An additional sample was treated with acyclovir to
halt viral replication prior to EBV genome replication. The
chromatin was fixed by application of 1% (v/v) formalde-
hyde for 15 min at 20◦C, extracted as described in Bark-
Jones et al. (36) then sonicated on ice (10 × 10 s-pulses;
30% amplitude output) on a Bransonmodel 250Microtip at
setting 5 (Sonics Vibacell). The chromatin was pre-cleared
with protein A/G-sepharose bead slurry (Sigma) that had
been pre-blocked in 0.5% (w/v) fraction V BSA (Sigma)
in DPBS. 2% (v/v) of the pre-cleared extract was retained
as the input control sample while the remainder was incu-
bated with 10 g of Zta-specific goat antibody (Santa Cruz
# sc-17503) or control goat IgG for 1 h at 4◦C as described
in Ramasubramanyan et al. (20). The input control sample
and the precipitatedDNAwere sequentially treatedwith 0.2
g/ml RNAseA and 0.2 g/ml Proteinase K and the DNA
purified. Sequencing libraries were prepared using 10 ng of
the input and ChIP DNA using a ChIP-seq sample prepa-
ration kit (Illumina) following the manufacturer’s protocol,
except that the library (150–350 bp fragments) was puri-
fied from the gel using a gel extraction kit (Qiagen) after
PCR-amplification. The libraries were sequenced (single-
end, 36 bp) using an Illumina Genome Analyzer IIx. Initial
processing of sequencing images was carried out using the
CASAVA pipeline. Base calling, and quality control statis-
tics were performed using GOAT and Bustard modules. Se-
quence reads were aligned to the hg19 release of the human
genome with ELAND. Bigwig files were generated by cal-
culating tag density in 10-bp window, normalizing per mil-
lion total reads and subtracting input signals using in-house
R scripts. Peak calling (P < 10−7) was performed from a
merged Bed file generated from the twoChIP-datasets using
MACS (37), with a merged input Bed file acting as back-
ground (GSE57732). Distances between binding sites and
the transcription start site annotated in RefSeq (38) were
calculated. Genes within 2 kb of a peak were scored as pro-
moter proximal. The Zta binding sequences associated with
peakswere analyzed for commonDNA-sequencemotifs us-
ing MEME-ChIP (39,40). Matches with both P and q val-
ues of <1.0E−034 were selected and common microsatel-
lite repeat sequences omitted. Functional gene enrichment
analysis was undertaken using the DAVID bioinformatics
resource at the National Institute of Allergy and Infectious
Diseases (NIAID) (41,42).
ChIPwas undertaken from chromatin generated from the
spontaneously lytic LCL cell line LCL#3. Enrichment was
quantified using Q-PCR spanning Zta binding peaks iden-
tified in the Akata cell line and flanking regions ∼2 kb 5′ or
3′ to them. The DNA sequences of each of the primers is
shown in Table 1.
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Figure 2. Comparison of Zta binding patterns in BL, LCL and NPC cells. (A) Examples of ChIP-seq data from Akata cells aligned to the human genome
surrounding the SCIMP locus (chr17:5 096 004–5 154 368, hg19) is shown using the UCSC genome browser. The depth of sequencing reads from Zta-
enriched DNA is plotted per million background-subtracted total reads. The scale bar and genome location are shown, together with the Zta binding
profile. Beneath this are the peaks of Zta binding identified using MACs (P < 10−7), with the RefSeq gene mapping shown below that. (B) The presence
of Zta binding in LCL#3 is shown at the SCIMP locus using Q-PCR with primers corresponding to the Zta binding sites (peak) and a flanking region 2
kb distant (flank). The data from triplicate analyses show the percentage of binding relative to input chromatin. The DNA binding associated with Zta is
shown in black and the control antibody in gray. A horizontal line marks the baseline for the assay. (C) The presence of Zta binding in HONE1-EBV at the
SCIMP locus is shown (as in B). (D) Examples of ChIP-seq data from Akata cells aligned to the human genome surrounding the BCL2A1 locus (chr15:80
241 085–80 275 791, hg19) is shown using the UCSC genome browser as in (A). (E). The presence of Zta binding in LCL#3 is shown at the BCL2A1 locus
using Q-PCR with primers corresponding to the binding sites and to two flanking regions 2 kb distant either side of the site as in (B). (F) The presence of
Zta binding in HONE1-EBV cells at the BCL2A1 locus is shown.
Table 2. Ten most enriched Gene Ontology biological process terms in the set of Zta-up regulated genes
GO term
Accession
number P Value Bonferroni Benjamini FDR
Cell projection organization GO:0030030 3.84E−14 1.34E−10 1.34E−10 7.04E−11
Cell morphogenesis GO:0000902 5.75E−14 2.01E−10 1.01E−10 1.05E−10
Cellular component
morphogenesis
GO:0032989 1.03E−13 3.62E−10 1.21E−10 1.89E−10
Biological adhesion GO:0022610 1.08E−13 3.79E−10 9.48E−11 1.98E−10
Neuron projection development GO:0031175 1.62E−13 5.67E−10 1.13E−10 2.97E−10
Cell adhesion GO:0007155 2.27E−13 7.95E−10 1.33E−10 4.16E−10
Cell morphogenesis involved in
differentiation
GO:0000904 7.67E−13 2.69E−09 3.84E−10 1.40E−09
Neuron projection morphogenesis GO:0048812 1.28E−12 4.49E−09 5.62E−10 2.35E−09
Cell projection morphogenesis GO:0048858 3.15E−12 1.10E−08 1.23E−09 5.77E−09
Cell morphogenesis involved in
neuron differentiation
GO:0048667 7.83E−12 2.74E−08 2.74E−09 1.43E−08
Reverse transcription and qPCR
Total RNA was prepared from Akata-Zta and Akata
control cells 24 h after addition of doxycycline using
RNAeasy Kit (Qiagen) and treated with RQ-DNAse
(Promega) and quantitated using a Nanodrop spectrome-
ter. First strand cDNAwas prepared using random primers
(Roche). Viral transcripts were amplified using absolute
quantitation with Sybrgreen Go-Taq Q-PCR (Promega)
with the following primers: BMLF1 (GACCGCTTCGAG
TTCCAGAAT; ACTCTCCCGAACTAGCAGCAT
and BDLF3 (TCGGTGGCAGTGATGTTCTG;
TTCCAACGCATCCACCATCA). Host cell RNAs
were also analyzed using TaqMan relative quantitation
RT-PCR in a high-throughput format using Gene cards
(Life Technologies, UK). Signals were normalized to
GAPDH expression and the relative difference in the
presence and absence of doxycycline determined. The fold
change in RNA abundance was calculated together with the
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Figure 3. Lytic cycle induction system. (A) A schematic diagram of the bi-directional expression vector encoding Zta and is shown. The control vector
has the Zta sequence cloned in the opposite direction. (B) Protein expression was assessed over 4, 8 and 24 h using immunoblotting for Zta and actin
as indicated. (C) The expression of Zta and the late lytic cycle protein VCA were determined in Akata Zta cells induced with doxycycline for 24 h using
multi-parameter FACS analysis. The data are expressed as the% of the GFP positive cells that also stain for Zta and VCA compared to a control antibody.
(D) Expression levels of the viral genes BMLF1 and BDLF3 mRNA were assessed using RT-coupled Q-PCR. The relative change in abundance of the
mRNA is shown with the error bars relating to triplicate cell induction experiments and standard deviation. (E) The relative amount of viral compared to
human DNA (viral genome load) was determined by Q-PCR 24 h after doxycycline addition. This is shown with the mean and standard deviation from
triplicate assays. (F) Cells were induced with doxycycline for 24 h and Zta expressing and control cells were enriched with anti-NGFR coated magnetic
beads. The proportion of cells that express GFP is shown for both the pre-enriched and post-enriched populations of cells.
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Figure 4. Global transcriptome analysis of gene expression changes reprogrammed during viral replication. (A) The expression of cellular genes in two
enriched populations of Akata-control and Akata-Zta cells induced with doxycycline for 24 h were assessed using RNA-seq. The distribution of genes with
a change in expression of at least two and a false discovery rate (FDR) ≤ 0.01 are shown in red on the MA plot (log total counts versus log fold-change).
(B) Percentage of genes enriched (Bonferroni-modified P ≤ 0.01) for Biological Function categories. Data are shown for all genes (black), those that are
up regulated (gray) and those that are down regulated (open).
Table 3. Ten most enriched Gene Ontology biological process terms in the set of Zta-down regulated genes
GO term
Accession
number P Value Bonferroni Benjamini FDR
Immune response GO:0006955 1.67E−08 3.57E−05 3.57E−05 2.89E−05
Induction of apoptosis GO:0006917 2.02E−07 4.31E−04 2.16E−04 3.49E−04
Induction of programmed cell
death
GO:0012502 2.15E−07 4.59E−04 1.53E−04 3.72E−04
Positive regulation of apoptosis GO:0043065 2.66E−07 5.68E−04 1.42E−04 4.60E−04
Positive regulation of programmed
cell death
GO:0043068 3.06E−07 6.55E−04 1.31E−04 5.30E−04
Positive regulation of cell death GO:0010942 3.43E−07 7.35E−04 1.23E−04 5.95E−04
Lymphocyte activation GO:0046649 5.24E−07 1.12E−03 1.60E−04 9.08E−04
Cell activation GO:0001775 1.14E−06 2.45E−03 3.06E−04 1.98E−03
Regulation of apoptosis GO:0042981 3.37E−06 7.18E−03 8.01E−04 5.84E−03
Regulation of programmed cell
death
GO:0043067 4.38E−06 9.33E−03 9.37E−04 7.59E−03
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Figure 5. Intersection of ChIP-seq and RNA-seq data. (A) The diagram shows the intersection between genes associated with a Zta binding peak (brown)
and genes that are regulated during EBV lytic cycle (green). (B) The percentage of all cellular genes and the percentage of the sub-set of cellular genes that
are associated with Zta binding and up regulated during lytic cycle was compared. The significant increase in the percentage of up regulated genes that are
also associated with Zta binding is highlighted (P < 0.01, Binomial distribution (cumulative), n = 92).
standard deviation from three independent cell enrichment
experiments. The TaqMan primer sets were as follows:
GAPDH-Hs99999905 m1; FOSB-Hs00171851 m1;
SCIMP-Hs010294 m1; AN01-Hs00216121 m1; GDF2-
Hs00211913 m1; FSCN1-Hs00602051 mH (Life Tech-
nologies, UK).
RNA-Seq
Sequencing was performed on biological duplicates of
Akata-Zta and Akata control samples on the Illu-
mina HiSeq 2500 platform and generated ∼45 mil-
lion 101-bp paired-end reads per sample. The data
are deposited in GEO (GSE57732). Sequenced reads
were mapped to RefSeq genes archived in the Illu-
mina iGenomes resource (https://support.illumina.com/
sequencing/sequencing software/igenome.ilm using RSEM
(version 1.2.4; (43)). An existing pipeline developed
within the Trinity software package (http://trinityrnaseq.
sourceforge.net/analysis/diff expression analysis.html) (44)
was used to perform differential expression analysis
with edgeR (version 3.01; http://www.bioconductor.org/
packages/release/bioc/html/edgeR.html), which is available
as part of the Bioconductor project developed within the R
programming language (45). Genes with logCPM> 0, fold-
changes above 2-fold and FDR<0.01 were judged to be dif-
ferentially expressed. Genes with a total read count below
20 were excluded from further analysis. Views of the data
are plotted using the Integrative Genomics Viewer (IGV)
(46).
DNA analysis
Total cell DNAwas prepared from cells and the amounts of
EBV genome relative to human genome determined using
Q-PCR as described (47).
RESULTS
Candidate targets of Zta in the human genome
To determine whether Zta interacts with human genes dur-
ing the switch from latency to lytic EBV replication, we
undertook a genomic-scale analysis of Zta binding sites in
AkataEBV-positive BL cells. Lytic replicationwas activated
by engagement of the cell surface B-cell receptor (BCR)
with anti-immunoglobulin. After crosslinking the proteins
to DNA using formaldehyde, chromatin from the activated
cells was immunoprecipitated with a previously validated
Zta antibody (20,47) and the precipitated DNA was ana-
lyzed by massively parallel DNA sequencing (ChIP-seq).
Significant regions of interaction between Zta and the cellu-
lar genome were identified using the Model-based Analysis
of ChIP-Seq (MACS) algorithm (37). This identified 5020
Zta binding peaks (P ≤ 1×10−7). Using a motif-based se-
quence analysis tool (MEME-ChIP) (39,40) to search for
enriched motifs we noted that the most frequent consen-
sus sequences resembled the previously described non-CpG
containing and CpG containing ZRE motifs from the EBV
genome (16,17,20), suggesting that Zta directly binds to
these sites in the human genome.
Although some of the Zta binding sites (14%) were close
to the annotated transcriptional start sites (TSS) of cellular
genes (Figure 1B and Supplementary Table 1), analogous to
the situation observed for the interaction of Zta with viral
genes, the majority of the Zta binding sites (86%) were more
distant (≥4 kb from the nearest TSS). By assigning each of
the Zta peaks to the closest TSS, irrespective of distance,
we identified 2395 cellular genes as potential candidates for
regulation by Zta.
To validate the ChIP-seq, we chose representative ex-
amples of cellular genes associated with Zta binding sites,
based on the patterns of Zta binding and amenability to
analysis by Q-PCR using PCR primer sets that would dis-
criminate enhanced binding within the peak region rela-
tive to the adjacent DNA. We also determined whether Zta
binding occurs in different cell types in which EBV under-
goes lytic replication: the LCL#3 lymphoblastoid cell line
(30) and HONE1-EBV, a cell line derived from a nasopha-
ryngeal carcinoma (48). Examples of the analysis of Zta
binding at the SCIMP and BCL2A1 genes are shown in
Figure 2A and D. In both cases, Zta binding was enriched
within the peak region identified by ChIP-seq in Akata cells
undergoing lytic replication (Figure 2B, C, E and F). This
demonstrates that the specific interaction between Zta and
these genes occurs in three different cell backgrounds.
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Figure 6. Changes in RNA abundance for five cellular genes after induction of EBV lytic replication cycle in Akata cells. (A–E) The raw RNA-seq reads
from two independent isolations of mRNA for control and Zta expressing cells are aligned to the human genome at ANO1; GDF2; FSCN1; SCIMP and
FOSB loci using the IGV genome browser. A scale bar is shown above each region. The location of the Zta binding sites is shown in black. (F) RNA was
prepared from Akata cells following crosslinking BCR with anti-IgG for 48 h. Changes in the expression of each gene: ANO1; GDF2; FSCN1; SCIMP
and FOSB were determined using TaqMan RT-PCR. The fold induction data is shown (with BCR ligation, b), together with the fold change from the
doxycycline induced Akata Zta and Akata controls cells (with dox, a).
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Figure 7. Location of Zta binding sites at up regulated genes. (A) The figure shows the percentage of up regulated genes with Zta binding sites within 2 kb,
between 2 and 4kb and >4 kb from a TSS. (B) The percentage of up regulated genes with 1, 2–4 or >5 Zta binding sites. (C) The numbers of sequencing
reads from Zta-enriched DNA at the GDF2 locus (chr10:48 397 968–48 431 996, hg19) are plotted per million background-subtracted total reads and
aligned with the human genome. The scale bar and genome location are shown, together with the Zta binding. Beneath this are the peaks identified using
MACS (P < 10−7) and RefSeq gene mapping (UCSC genome browser). (D) Similar data for the region surrounding the RASA3 locus (chr13:114 709
728–114 936 080, hg19). (E) Similar data for the region surrounding the FOSB locus (chr19:45 947 279–45 995 778 hg19).
Changes in the cell transcriptome during EBV lytic cycle
To explore the significance of Zta binding throughout the
genome of Akata cells, we wanted to establish whether any
of the genes associated with Zta binding sites are transcrip-
tionally regulated during the EBV lytic replication cycle.
Previous attempts to investigate changes in cellular gene ex-
pression during the EBV lytic cycle have been limited by the
low percentage of Akata cells that undergo EBV lytic repli-
cation following BCR engagement. To optimize the identi-
fication of regulated genes, we introduced an inducible Zta
expression vector with a selectable marker gene (32) into
Akata cells to allow lytic cycle induction in a high propor-
tion of cells (Figure 3A). In parallel, a cell linewas generated
with a vector in which the BZLF1 sequences were inserted
in the opposite orientation. This cell line was used as a com-
parator throughout the investigation to control for any im-
pacts of the inducing agent on cells. Addition of doxycy-
cline resulted in the rapid induction of Zta expression (Fig-
ure 3B and C) with no associated toxicity (Supplementary
Figure S1). This was accompanied by activation of the EBV
lytic cycle, as judged by the expression of the late gene VCA
(Figure 3C), expression of the viral early gene BMLF1 and
late gene BDLF3 (Figure 3D) and replication of the viral
genome (Figure 3E). No evidence for lytic replication was
observed in the control cells. It is important to note that
although a higher percentage of cells express Zta protein
in the inducible system compared to BCR stimulation, the
abundance of Zta protein is equivalent in the two systems
as judged by intracellular staining and FACS analyses (Sup-
plementary Figure S2). Thus, the level of Zta expression in-
duced by doxycycline is physiologically relevant.
Populations of control and Zta expressing cells were en-
riched by selection on anti-NGFR coupled magnetic beads.
This generated pools of cells in which greater than 70%
expressed the induced genes (Figure 3F and Supplemen-
tary Figure S3), in which both the down regulation and
the up regulation of gene expression can be determined.
This was undertaken for two independently enriched pop-
ulations of Zta expressing and control cells by sequencing
the polyadenylated transcripts (RNA-seq). Differential ex-
pression analysis identified 2263 cellular genes whose ex-
pression changed >2-fold following induction of the lytic
cycle (FDR≤0.01) (Figure 4 and Supplementary Table S2).
This included 2242 novel targets and 21 genes that had been
identified in previous studies (27,28). Of the genes identi-
fied in this analysis, 1679 were up regulated and 584 were
down regulated. The genes fell into many functional groups
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Figure 8. Zta can activate gene expression through a long-range element. (A) A synthetic element containing tandem ZREs was cloned 2.2 kb from either
of two minimal promoters (minC and minP) in the pGL3 control luciferase reporter plasmid. (B) Promoter activities of the pGL3 based plasmids SV40p,
minC-Null andminCZREs in the presence (black) and absence (gray) ofHis-Zta expression in the EBV negative BL cell line (DG75). The relative luciferase
activity is shown as promoter activity together with the standard deviation from three replicates. (C) Western blot analysis of Zta and Actin from samples
in (B). (D) Promoter activity of the minP-Null andminP-ZREs reporters in the presence and absence of His-Zta expression in the EBV negative BL cell line
(DG75). The relative luciferase activity is shown as promoter activity together with the standard deviation from three replicates. (E) Western blot analysis
of Zta and actin from samples in (B).
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Figure 9. Zta can activate gene expression through binding sites associated with FOSB. (A) The DNA sequences at three Zta binding sites associated with
FOSBwere cloned upstream from an EBV lytic cycle promoter BHLF1 containing no ZREs (BHLF1mut) to generate BHLF1mut FOSB. A control region
from the human genome is also included. (B) Promoter activity of BHLF1mut, BHLF1mut control and BHLF1mut FOSB in the presence and absence
of His-Zta expression in the EBV negative cell line (DG75). The relative luciferase activity is shown as fold regulation by Zta with the standard deviation
from three replicates. (C) Western blot analysis of Zta and Actin from samples in (B).
but gene ontology analyses showed that among the up reg-
ulated genes, significant enrichment was observed for genes
involved in cell adhesion, morphogenesis, projection and
response to hormones (Table 2 and Figure 4). Within the
down regulated category, there was significant enrichment
for genes involved in the immune response, induction of
apoptosis and lymphocyte activation (Table 3 andFigure 4).
Regulation of Zta-associated genes
Although the presence of a transcription factor on a gene
can be indicative of a regulatory role, it is not definitive:
transcription factor binding can occur without discernible
changes in gene expression. We therefore asked which of
the 2395 cellular genes associated with Zta binding are reg-
ulated following Zta induction of the EBV lytic cycle. Of
the genes whose expression changed ≥ 2-fold in this ex-
periment, 278 were associated with Zta binding sites and
are therefore candidates for direct Zta-mediated regulation
(Figure 5A). Of these, 207 genes were up regulated and 71
were down regulated. The presence of one ormore Zta bind-
ing site correlated with an increased likelihood that a gene
was up regulated (P= 0.014, Binomial distribution, n= 92)
(Figure 5B). In contrast, there was no specific enrichment
for Zta binding sites in the down regulated genes.
The proportion of genes associated with Zta binding that
are demonstrably regulated during EBV lytic replication in
BL cells (11.6%) is typical of many cellular transcription
factors. Published reports suggest that between 1% and 10%
of transcription factor associated genes are transcription-
ally altered by expression of the transcription factor (49–
52).
The Zta-bound genes that are also up regulated during
EBV lytic cycle, listed in Supplementary Table 3, are the
most likely candidates to be regulated directly byZta andwe
focused our follow-up analysis on these.We chose a panel of
five representative genes in which the Zta binding sites were
in different positions relative to the TSS: SCIMP1, FOSB,
ANO1, GDF2 and FSCN11. Figure 6 shows the aligned
RNA sequence data and the locations of Zta binding sites.
For each gene, we obtained appropriate Taq-man probes
and quantified the changes in abundance of the RNA in
Akata cells following the ligation of BCR by cross-linking
with anti-IgG. All of the RNAs showed increased abun-
dance following BCR ligation (Figure 6E), although the ef-
fects were difficult to quantify because signals in the unli-
gated cells were below the levels of detection.
Patterns of Zta binding at regulated genes
Having validated the RNA-seq data at selected targets, we
asked whether there was any general correlation between
the number and location of Zta binding sites and the ob-
served effects on gene expression at up regulated genes (Fig-
ure 7). Although ∼15% of the Zta binding sites were within
2 kb of a TSS, in line with the established model of Zta me-
diated gene activation of viral promoters, it was clear that
the majority (75%) of the Zta binding sites were distal (>4
kb) to the nearest TSS. Approximately half of the up regu-
lated genes associated with a Zta binding site have a single
peak whereas the others have two or more (Figure 7).
At some genes, Zta binding was relatively confined as ex-
emplified by the up regulated GDF2 gene where a cluster of
four Zta binding sites was observed at the 3′ end of the gene,
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Figure 10. Zta can activate gene expression through binding sites associated with RASA3. (A) The DNA sequences at seven Zta binding sites associated
with the 3′ region ofRASA3were cloned in the enhancer position>2 kb from the minP promoter to generate minP-RASA3. (B) Promoter activity of minP
null and RASA3 minP in the presence and absence of His-Zta expression in the EBV negative cell line (DG75). The relative luciferase activity is shown
with the standard deviation from three replicates. (C) Western blot analysis of Zta and Actin from samples in (D).
6–8 kb from the transcription start site (Figure 7C). How-
ever, at other genes, exemplified by RASA3 and FOSB, Zta
binding peaks were found 5′ of the transcription start sites,
within intragenic regions and 3′ of the genes, distributed
over considerable distances (Figure 7D and E).
Zta binding sites act as transferable regulatory elements
The ability of Zta to activate transcription by binding to
promoter elements is well documented (53) but we are not
aware of any previous reports that Zta can act through distal
regulatory elements. To gain support for the idea that Zta
can also influence transcription from a distance, we gener-
ated luciferase reporter constructs in which a tandem ar-
ray of non CpG ZREs was cloned into a classical enhancer
vector, 2.2 kb upstream of one of two minimal promoters
(Figure 8A and Supplementary Figure S2). Tandem arrays
of ZREs embedded within minimal promoters have been
previously used to measure Zta activity (54,55), but action
away from a promoter has not been assessed. In the MinC-
ZREs reporter, we used a minimal promoter derived from
the CIITA gene, which is not regulated by Zta. An alter-
native reporter, designated MinP-ZREs, was based on the
minimal promoter in the commercially sourced pGL4.23
reporter vector (Promega). In each case, we compared the
activity of the promoters with and without the ZREs, with
an SV40 promoter construct as an additional control (Fig-
ure 8B and D). The reporter plasmids were introduced into
EBV negative DG75 BL cells, together with a vector en-
coding Zta or empty vector control. Immunoblotting con-
firmed that Zta was expressed at equivalent levels in the
transfected cell populations (Figure 8C and E). Whereas
Zta had a minimal effect on the activity of the MinC and
SV40 promoters, the inclusion of the ZRE array resulted
in an 8-fold increase in the activity of the MinC construct.
Similarly, although Zta appeared able to activate the MinP
promoter on its own, the presence of the ZRE array resulted
in more substantial activation (75-fold versus 13-fold). The
6-fold differential between these effects is consistent with
the impact of the ZRE array on the MinP promoter. Taken
together, the data suggest that Zta can regulate gene expres-
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sion via ZRE elements that are located at a distance from
promoters, in a classical enhancer assay.
We then asked whether authentic Zta binding sequences
from the cellular targets genes can be transferred onto a het-
erologous promoter. We chose the FOSB andRASA3 genes
as examples. In FOSB each of the four non-CPG Zta bind-
ing sites was ≥2 kb from the FOSB TSS (16 and 9 kb up-
stream, 2.4 and 10 kb downstream) and the gene is up reg-
ulated during the EBV lytic replication cycle (Figure 7E).
We cloned the Zta binding sites from −16 and −9 kb up-
stream from a viral promoter (BHLF1mut) that had been
rendered unresponsive to Zta by virtue of mutations in each
of its ZREs (Figure 9A).We also included a similar size con-
trol region from the cellular genome. The reporter plasmids
were transfected into DG75 cells, together with a plasmid
encoding Zta or the empty vector control. The presence of
the FOSB sequences caused a 2.5-fold increase in the re-
sponse of the promoter to Zta compared to the controls
(Figure 9B). Equivalent expression of Zta protein was seen
for all reporters (Figure 9C).We therefore conclude that the
distal Zta binding sites from the FOSB gene are able to con-
fer Zta responsiveness. For RASA3, where there are multi-
ple Zta binding sites across a >100 kb region, we focused
on elements within seven Zta binding sites from the 3′ end
of theRASA3 gene (≥40 kb from the TSS). These conferred
Zta-mediated induction of expression of theminP promoter
when cloned into the enhancer position of the PGL3 lu-
ciferase reporter vector. The average increase in expression
was 2.2-fold over three experiments (Figure 10), which is in
line with typical ESC enhancers in similar assays (56).
DISCUSSION
We identified 2263 cellular genes whose expression is signif-
icantly altered within the first 24 h of initiation of the EBV
lytic cycle. This was surprising given that a process termed
host cell shut-off, driven by the EBV lytic replication cy-
cle gene BGLF5, is reported to promote a global reduction
in cellular gene expression during the EBV lytic replication
cycle (57–59). The regulation of cellular genes that we ob-
serve must therefore occur either in advance of the impact
of BGLF5 gene expression or perhaps in spite of it.
It is possible that the cellular genes that are regulated dur-
ing the EBV lytic replication cycle are specifically targeted
to aid the success or the efficiency of viral replication. In-
deed, we found a significant enrichment for genes involved
in specific biological functions. For example, 190 of the up
regulated genes are involved in cell morphogenesis (P ≤
1.0−10). We speculate that these genes might facilitate viral
assembly or genome encapsulation in the nucleus, the ex-
port of immature virions from the nucleus, transport and
further assembly within the cytoplasm, or egress from the
cell. Among the down regulated group of genes, there was
a specific enrichment for genes involved in apoptosis. It is
well established that BL cells undergoing EBV lytic replica-
tion are protected from apoptosis (60) and the down regula-
tion of the cellular genes identified here might contribute to
the observed protection. This suggests that EBVmight have
evolved a strategy to reprogram cellular gene expression in
order to tailor the environment of the cell for optimal viral
replication.
During the early stages of the EBV lytic replication cy-
cle, several viral genes, including the transcription factors
Zta and Rta and the post-transcriptional regulator BSLF2
+ BMRF1, act in concert to regulate the expression of the
viral genome (53). In this scenario, it is clear that induction
of Zta expression in Akata cells could drive both direct reg-
ulation of the host cell transcriptome and instigate indirect
regulation of genes through the action of other lytic cycle
proteins. It was therefore important to consider which of
the 2263 host genes whose expression was altered following
Zta activation were associated with a Zta binding peak dur-
ing the EBV lytic replication cycle. Integration of the data-
sets provided 278 cellular genes as candidates for direct Zta-
mediated transcriptional regulation.
One of the unexpected findings was that the majority of
the Zta binding sites identified in this set of cellular genes
are distal to promoters. This is very different from the situ-
ation observed in the viral genome where functional ZREs
have been shown to lie in very close proximity to transcrip-
tion start sites (16,20). Indeed, the interaction of Zta with
RNA polymerase II accessory proteins is considered to aid
the activation of transcription from viral promoters (61–
64). The location of the cellular Zta binding sites suggested
to us that Zta reprograms the regulation of cellular genes
through a different mode of action. In support of this idea,
we present two lines of evidence. First, we find that a tandem
array of ZREs has enhancer-like activity when located dis-
tal to a minimal promoter in a classical enhancer reporter
assay. Second, we find that the Zta binding sites from the
cellular FOSB andRASA3 genes can transfer Zta-mediated
activation onto heterologous promoters. Although the im-
pact is modest, it is in line with the magnitude of regula-
tion recently reported for cellular enhancers in the context
of plasmid based reporter assays (56). As the reporter gene
regulation occurs in the absence of other EBV gene expres-
sion, it supports the hypothesis that Zta is able to directly
activate cellular genes through regulatory elements that lie
distal to their transcription start sites. This raises the possi-
bility that long-range gene mechanisms act through direct-
ing through chromatin looping, in a similar manner to that
recently described for the EBVEBNAgenes (65,66). In light
of the discovery of Zta regulation through distal Zta bind-
ing sites, it will be relevant to reconsider the interactions of
Zta with the viral genome (16,20), with regards to the po-
tential for regulation of distant promoters.
SUPPLEMENTARY DATA
Supplementary Data are available at NAR Online.
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